Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Inspire-Robots | 2026 | Series C | Undisclosed | Haidian |
| BreezeBio | 2026 | Series B | $60.0M | Brisbane |
| GluBio Therapeutics | 2026 | Corporate Round | $30.0M | Hangzhou |
| Shengshu Technology | 2026 | Series A | $86.4M | Haidian |
| Microtide Biotechnology | 2026 | Series A | $22.5M | Shanghai |
| StepFun | 2026 | Series B | $718.1M | Xuhui |
| Nature Select | 2026 | Series Unknown | $30.0M | — |
| XellSmart | 2026 | Series C | Undisclosed | Minhang |
| Zenitar | 2026 | Series C | $86.0M | Chengdu |
| Oricell Therapeutics | 2026 | Series C | $70.0M | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Inspire-Robots | Series C | Undisclosed | Haidian, China |
| 52 | BreezeBio | Series B | $60.0M | Brisbane, United States |
| 53 | GluBio Therapeutics | Corporate Round | $30.0M | Hangzhou, China |
| 54 | Shengshu Technology | Series A | $86.4M | Haidian, China |
| 55 | Microtide Biotechnology | Series A | $22.5M | Shanghai, China |
| 56 | StepFun | Series B | $718.1M | Xuhui, China |
| 57 | Nature Select | Series Unknown | $30.0M | — |
| 58 | XellSmart | Series C | Undisclosed | Minhang, China |
| 59 | Zenitar | Series C | $86.0M | Chengdu, China |
| 60 | Oricell Therapeutics | Series C | $70.0M | Shanghai, China |
Inspire-Robots is a supplier of robot core components and intelligent operation solutions.
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
Shengshu Technology is a generative AI infrastructure that develops native multi-modal large models such as images, 3D, and video.
Microtide Biotechnology an innovative company in the field of in vivo cell therapy.
StepFun is an AI technology company that develops large language models and multimodal AI systems to process and generate text.
Nature Select is a software company that develops AI memory models, multimodal interaction systems, and 3D interactive gameplay.
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.
OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.
Powering precision proteomics to enable to the earliest detection of disease.
Langmu Medical is a technological start-up company that focuses on innovative ophthalmic medical devices.
PRCXI Biotechnology is a biotech company that focuses on analytical instruments, bioinformatics and automation solutions for life sciences.
Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots.
Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.
Makera develops desktop CNC machines and software designed for makers, educators, small businesses, and laboratories.
SonoSilicon researches on medical-grade micro-on-chip ultrasound systems and chip design and promotes the medical device industry.
Green Energy Origin is a sustainable firm that develops specialty chemicals and battery raw materials for cost effective energy solutions.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases.
ChemLex is a chemical synthesis CRO that was founded by Magera Technology.
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools.
Shenkepu Industry provides industrial process automation solutions and uses high-end process equipment.
ByteDance is a technology company that develops content creation platforms and services.
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Medical, Pharmaceutical, Health Care, Artificial Intelligence (AI). The firm invests across 35 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post Ipo Equity round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include Inspire-Robots, BreezeBio, GluBio Therapeutics, Shengshu Technology, Microtide Biotechnology. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors